Sotorasib in KRAS-Mutated Colorectal Cancer. Reply
- PMID: 38986068
- DOI: 10.1056/NEJMc2406109
Sotorasib in KRAS-Mutated Colorectal Cancer. Reply
Comment on
-
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.N Engl J Med. 2023 Dec 7;389(23):2125-2139. doi: 10.1056/NEJMoa2308795. Epub 2023 Oct 22. N Engl J Med. 2023. PMID: 37870968 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous